Next Bay Area IPO teed up for Thursday, another slashes targets

The second Bay Area IPO of the year is marching toward its Wall Street debut on Thursday, while a microcap offering gets smaller. Redwood City-based Revolution Medicines Inc. hopes to raise up to $184 million in an offering that would give it a market cap of between $846 million and $870 million if it hits the top of its price targets. It was valued at about $475 million after raising a private funding round last summer, acc ording to PitchBook Data. Its biggest stakeholder is Boston-based Third…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news